asacol magasýruþolin tafla 400 mg
tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 400 mg
asacol magasýruþolin tafla 800 mg
tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 800 mg
oropram filmuhúðuð tafla 10 mg
teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 10 mg
oropram filmuhúðuð tafla 20 mg
teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 20 mg
oropram filmuhúðuð tafla 40 mg
teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 40 mg
penthrox innöndunargufa, gegndreyptur stabbi 3 ml
medical developments ned b.v. - methoxyflurane - innöndunargufa, gegndreyptur stabbi - 3 ml
toilax sýruþolin tafla og endaþarmsdreifa
orion corporation - bisacodylum inn - sýruþolin tafla og endaþarmsdreifa
toilax endaþarmsdreifa 2 mg/ml
orion corporation - bisacodylum inn - endaþarmsdreifa - 2 mg/ml
thiamazole uni-pharma tafla 5 mg
uni-pharma kleon tsetis pharmaceutical laboratories s.a. - thiamazolum inn - tafla - 5 mg
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - fjölmörgum - bóluefni - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.